R&D >

Bionanosome

HOME > R&D > Bionanosome

Χ
Under construction please wait.
  • Bionanosome, trademark of MDimune, is a novel concept of drug delivery system developed to increase the efficacy and to reduce the toxicity of anti-cancer drug
  • Artificially manufactured exosome mimetic nanovesicles
  • Maintain similar topology with original cell
  • 50~400nm diameter (size can be controlled)
  • Major features as DDS
    • Active targeting system to tumor and inflammation sites
    • Avoid RES (reticuloendothelial system)
    • Encapsulate diverse anti-cancer agent (small molecule, peptide, siRNA, etc.)
  • Major features as Diagnosis system
    • Encapsulate/conjugate various imaging probes
    • Active targeting system to tumor and inflammation sites
    • Enable to detect brain disease